Part one of term paper
Scientists have finally found out why MPA medroxyprogesterone, otherwise known as Provera performs just as well in low doses in small children who are dealing with early sex traits, as it does for women in high doses with breast cancer. You may have heard of Provera before as the drug that delivers hormone replacement therapy for women who a ...

Part two of term paper
... when to start making steroids. Low doses of Provera have shown to bind to the receptors in the brain and block GnRH production. There are certain disorders that children can develop- when their GnRH is not released into the brain. For instance, gonadotropin-independent precocity, this is when the Childs ovaries or testes still make steroids even without the release of GnRH. Since these children are still producing steroids without GnRH being released, low doses of Provera are not effective ...